Erschienen in:
01.06.2007 | Poster presentation
Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
verfasst von:
EJ de Almeida Figueiredo, A Perez, E Knobel, JMA Souza, MB Ferri, M Knobel, M Nigri, P Silveira, RD Morsch, RH Passos
Erschienen in:
Critical Care
|
Sonderheft 3/2007
Einloggen, um Zugang zu erhalten
Excerpt
B-type natriuretic peptide (BNP) plasma levels have recently been demonstrated as significant neurohormonal markers of chronic heart failure (CHF) progression and prognosis. Additionally, clinical studies have shown that the calcium sensitizer levosimendan beneficially affects the central hemodynamics of CHF patients and improves their long-term prognosis. …